Laszlo Rovo
Szeged, CS, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Multidisciplinary aspects of pediatric cochlear implantation: anesthesiological considerations.
Journal: Cochlear implants international
Published: February 11, 2026
Self-assembled polymeric prodrug provides controlled cisplatin release and enhanced efficiency in local chemotherapy.
Journal: Journal of pharmaceutical sciences
Published: February 03, 2026
Tilorone suppresses TGF-β-driven fibroblast activation and restores BMP-Smad1/5/8 signaling: implications for laryngotracheal fibrosis.
Journal: Journal of translational medicine
Published: November 27, 2025
MRI evaluation of the Osia® 2 hearing implant with OSI300 actuator: insights from a full-head cadaver model.
Journal: Cochlear implants international
Published: October 14, 2025
Evaluation of ChatGPT's responses to symptom-oriented questions in otolaryngology
Journal: Orvosi hetilap
Published: July 23, 2025
Injection laryngoplasty for the treatment of unilateral vocal fold paralysis
Journal: Orvosi hetilap
Published: April 19, 2025
Presentation of complex laryngotracheal surgeries using CT-based 3D models and 3D printing: a technical note.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: February 24, 2025
Preparation, and ex vivo and in vivo Characterization of Favipiravir-Loaded Aspasomes and Niosomes for Nose-to-Brain Administration.
Journal: International journal of nanomedicine
Published: February 13, 2025
Development, in vitro and ex vivo characterization of lamotrigine-loaded bovine serum albumin nanoparticles using QbD approach.
Journal: Drug delivery
Published: February 04, 2025
Tilorone attenuates high-fat diet-induced hepatic steatosis by enhancing BMP9-Smad1/5/8 signaling.
Journal: GeroScience
Published: February 01, 2025
Trastuzumab Decreases the Expression of G1/S Regulators and Syndecan-4 Proteoglycan in Human Rhabdomyosarcoma.
Journal: International journal of molecular sciences
Published: January 30, 2025
Last Updated: 09/26/2026